UB Paderborn / Katalog / Suche / in CDI

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Brain research, 2013-05, Vol.1510, p.48-62

2013

Link zum Volltext

Verfügbarkeit prüfen

A behavioural operant discrimination model for assessment and pharmacological manipulation of visual function in rats

Brain research, 2010-03, Vol.1321, p.78-87

2010

Link zum Volltext

Verfügbarkeit prüfen

AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

The Journal of pharmacology and experimental therapeutics, 2014-08, Vol.350 (2), p.212

2014

Link zum Volltext

Verfügbarkeit prüfen

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Journal of pharmacological and toxicological methods, 2016-09, Vol.81, p.295-305

Swedberg, Michael D.B.

2016

Link zum Volltext

Verfügbarkeit prüfen

mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties

The Journal of pharmacology and experimental therapeutics, 2014-04, Vol.349 (1), p.155

2014

Link zum Volltext

Verfügbarkeit prüfen

A proactive nonclinical drug abuse and dependence liability assessment strategy: a sponsor perspective

Behavioural pharmacology, 2013-09, Vol.24 (5-6), p.396

Swedberg, Michael D B

2013

Link zum Volltext

Verfügbarkeit prüfen

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

The Journal of pharmacology and experimental therapeutics, 2014-08, Vol.350 (2), p.469

2014

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Novel GABA Uptake Inhibitors. 3. Diaryloxime and Diarylvinyl Ether Derivatives of Nipecotic Acid and Guvacine as Anticonvulsant Agents

Journal of medicinal chemistry, 1999-09, Vol.42 (18), p.3447-3462

1999

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Novel GABA Uptake Inhibitors. 4. Bioisosteric Transformation and Successive Optimization of Known GABA Uptake Inhibitors Leading to a Series of Potent Anticonvulsant Drug Candidates

Journal of medicinal chemistry, 1999-10, Vol.42 (21), p.4281-4291

1999

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Novel γ-Aminobutyric Acid (GABA) Uptake Inhibitors. 5. Preparation and Structure−Activity Studies of Tricyclic Analogues of Known GABA Uptake Inhibitors

Journal of medicinal chemistry, 2001-06, Vol.44 (13), p.2152-2163

2001

Link zum Volltext

Verfügbarkeit prüfen

Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist Activity

Journal of medicinal chemistry, 1998-10, Vol.41 (22), p.4378-4384

1998

Link zum Volltext

Verfügbarkeit prüfen

1,2,5-Thiadiazole Analogues of Aceclidine as Potent m1 Muscarinic Agonists

Journal of medicinal chemistry, 1998-01, Vol.41 (3), p.379-392

1998

Link zum Volltext

Verfügbarkeit prüfen

Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans

The Journal of pharmacology and experimental therapeutics, 2001-12, Vol.299 (3), p.1056

2001

Link zum Volltext

Verfügbarkeit prüfen

Muscarinic Analgesics with Potent and Selective Effects on the Gastrointestinal Tract: Potential Application for the Treatment of Irritable Bowel Syndrome

Journal of medicinal chemistry, 1997-02, Vol.40 (4), p.538-546

1997

Link zum Volltext

Verfügbarkeit prüfen

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Journal of medicinal chemistry, 1998-01, Vol.41 (1), p.109-116

1998

Link zum Volltext

Verfügbarkeit prüfen

Drug discrimination: A model for detection of psychoactive effects

Journal of pharmacological and toxicological methods, 2011-07, Vol.64 (1), p.e23-e23

Swedberg, Michael D.B.

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessment of abuse liability using rat self-administration: Methodological considerations

Journal of pharmacological and toxicological methods, 2011-07, Vol.64 (1), p.e23-e24

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of novel GABA uptake inhibitors. Part 6 : Preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives

Bioorganic & medicinal chemistry, 2001-11, Vol.9 (11), p.2773-2785

2001

Link zum Volltext

Verfügbarkeit prüfen

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

Schizophrenia research, 2001-04, Vol.49 (1), p.193-201

2001

Link zum Volltext

Verfügbarkeit prüfen

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic

The Journal of pharmacology and experimental therapeutics, 1997-05, Vol.281 (2), p.876

1997

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity

The Journal of pharmacology and experimental therapeutics, 1997-05, Vol.281 (2), p.884

1997

Link zum Volltext

Verfügbarkeit prüfen

NNC 19-1228 and NNC 22-0031, novel neuroleptics with a mesolimbic-selective behavioral profile

Psychopharmacologia, 1997-01, Vol.129 (2), p.168-178

1997

Link zum Volltext

Verfügbarkeit prüfen

M1 receptor agonist activity is not a requirement for muscarinic antinociception

The Journal of pharmacology and experimental therapeutics, 1997-05, Vol.281 (2), p.868

1997

Link zum Volltext

Verfügbarkeit prüfen

Drug discrimination procedures: roles of relative stimulus control in two-drug cases

Psychopharmacologia, 1985, Vol.86 (4), p.444-451

1985

Link zum Volltext

Verfügbarkeit prüfen

Compound drug discrimination learning

Drug development research, 1989, Vol.16 (2-4), p.111-122

1989

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

A behavioural operant discrimination model for assessment and pharmacological manipulation of visual function in rats

AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties

A proactive nonclinical drug abuse and dependence liability assessment strategy: a sponsor perspective

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

Synthesis of Novel GABA Uptake Inhibitors. 3. Diaryloxime and Diarylvinyl Ether Derivatives of Nipecotic Acid and Guvacine as Anticonvulsant Agents

Synthesis of Novel GABA Uptake Inhibitors. 4. Bioisosteric Transformation and Successive Optimization of Known GABA Uptake Inhibitors Leading to a Series of Potent Anticonvulsant Drug Candidates

Synthesis of Novel γ-Aminobutyric Acid (GABA) Uptake Inhibitors. 5. Preparation and Structure−Activity Studies of Tricyclic Analogues of Known GABA Uptake Inhibitors

Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist Activity

1,2,5-Thiadiazole Analogues of Aceclidine as Potent m1 Muscarinic Agonists

Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans

Muscarinic Analgesics with Potent and Selective Effects on the Gastrointestinal Tract: Potential Application for the Treatment of Irritable Bowel Syndrome

Conformationally Constrained Analogues of the Muscarinic Agonist 3-(4-(Methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, Receptor Affinity, and Antinociceptive Activity

Drug discrimination: A model for detection of psychoactive effects

Assessment of abuse liability using rat self-administration: Methodological considerations

Synthesis of novel GABA uptake inhibitors. Part 6 : Preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic

Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity

NNC 19-1228 and NNC 22-0031, novel neuroleptics with a mesolimbic-selective behavioral profile

M1 receptor agonist activity is not a requirement for muscarinic antinociception

Drug discrimination procedures: roles of relative stimulus control in two-drug cases

Compound drug discrimination learning

Suchergebnisse filtern